SG001
Sponsors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd., CSPC Ouyi Pharmaceutical Co., Ltd., Shanghai JMT-Bio Inc., Shanghai Runshi Pharmaceutical Technology Co., Ltd, CSPC Megalith Biopharmaceutical Co.,Ltd.
Conditions
Advanced Biliary Tract CancerAdvanced Solid TumorAdvanced Solid TumorsAdvanced Solid TumoursCervical CancerEpithelial Ovarian CancerExtrahepatic CholangiocarcinomaFallopian Tube Cancer
Phase 1
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours
NCT03852823
Start: 2019-05-23End: 2023-03-31Target: 192Updated: 2021-04-30
A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors
NCT05508659
Start: 2022-09-20End: 2025-03-20Target: 128Updated: 2022-08-19
A Study of Simmitinib Plus SG001 in Advanced Solid Tumors
Not yet recruitingNCT06132217
Start: 2024-01-30End: 2027-01-30Target: 168Updated: 2023-11-15
A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.
Not yet recruitingNCT06136988
Start: 2023-12-31End: 2028-04-30Target: 129Updated: 2023-11-18
Safety and Efficacy of SYHA1813 Single Agent or in Combination With Different Regimens in Unresectable Locally Advanced or Metastatic Solid Tumors.
Not yet recruitingNCT06682611
Start: 2024-11-13End: 2027-11-13Target: 380Updated: 2024-11-12
Phase 2
Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer
NCT04886700
Start: 2021-07-31End: 2023-12-31Target: 104Updated: 2021-11-22
Efficacy and Safety of SG001 Combined With PLD in Patients With Platinum-resistant Relapsed EOC
NCT04983550
Start: 2021-09-30End: 2024-01-31Target: 126Updated: 2021-07-30
Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer
TerminatedNCT05009953
Start: 2021-09-01End: 2023-01-16Updated: 2024-07-11
A Study to Evaluate the Efficacy and Safety of SG001 in Combination With Nab-Paclitaxel in Patients With Advanced Triple-Negative Breast Cancer (TNBC)
NCT05068141
Start: 2021-10-01End: 2023-10-01Target: 79Updated: 2021-10-15
A Study of JMT101 in Patients With Metastatic Colorectal Cancer
NCT06089330
Start: 2024-01-31End: 2024-12-31Target: 102Updated: 2023-10-18
SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC
Not yet recruitingNCT06989671
Start: 2025-08-30End: 2028-07-30Target: 430Updated: 2025-08-27
Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
RecruitingNCT07183865
Start: 2025-03-09End: 2030-03-09Target: 44Updated: 2025-09-19